News

Goldman Sachs Sticks to Its Buy Rating for Regeneron (REGN)
In a report released on April 11, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron (REGN – Research Report), with a ...
Goldman cites a “positive surprise” for GSK ahead of ACIP meeting on RSV shot
GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.
CNBCTV183d
US Stock Markets Highlights: Wall Street slips as earnings roll on, Volatility cools from last week's spike
US stocks saw choppy trading on Tuesday (April 15) as investors digested a new round of first-quarter earnings reports and ...
7 Goldman Sachs insiders explain how the bank's new AI sidekick is helping them crush it at work
From analyst to partner, seven Goldman employees shared a look at how the bank's internal ChatGPT-like tool is making their ...
Goldman Sachs CEO David Solomon says he's telling clients to 'go slow' and wait for clarity on tariffs
"It's early to call heads or tails or direction of travel on how this will play out," CEO David Solomon said of Washington's ...
Goldman Sachs sees clients craving policy certainty — and putting off decisions — as deal backlog grows
Goldman Sachs reported revenue drops in two of its three main business lines, but trading revenue was enough to satisfy ...
Goldman Sachs CEO Sees 'Markedly Different Operating Environment' Entering Q2, Announces $40 Billion Stock Buyback
Goldman Sachs (NYSE:GS) reported higher first-quarter results, with revenue of $15.06 billion beating expectations at $14.81 ...
Goldman Sachs profit beats estimates as traders ride volatile markets
Goldman Sachs beat first-quarter profit estimates as its traders capitalized on volatile markets to bring in record equities ...